Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristie A Blum

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Blood|February 28, 2015
CD30: seeing is not always believingKristie A Blum
Hematology. American Society of Hematology. Education Program|January 18, 2011
Upcoming diagnostic and therapeutic developments in classical Hodgkin's lymphomaKristie A Blum
Hematology. American Society of Hematology. Education Program|December 10, 2021
Controversies in the management of early-stage Hodgkin lymphomaKristie A Blum
Cancer Journal (Sudbury, Mass.)|September 25, 2018
Treatment-Resistant Hodgkin Lymphoma: Defining the Role of Autologous TransplantationKristie A Blum
Hematology. American Society of Hematology. Education Program|December 6, 2015
B-cell receptor pathway modulators in NHLKristie A Blum
Current Treatment Options in Oncology|February 1, 2014
Ibrutinib in B-cell LymphomasKami Maddocks, Kristie A Blum
Cancer Treatment and Research|February 7, 2015
Treatment strategies in mantle cell lymphomaKami Maddocks, Kristie A Blum
Blood|November 19, 2015
How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplantLapo Alinari, Kristie A Blum
Expert Opinion on Biological Therapy|July 23, 2004
90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphomaKristie A Blum, Nancy L Bartlett
Seminars in Oncology|August 27, 2003
Antibodies for the treatment of diffuse large cell lymphomaKristie A Blum, Nancy L Bartlett
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Blood|February 28, 2015
CD30: seeing is not always believingKristie A Blum
Hematology. American Society of Hematology. Education Program|January 18, 2011
Upcoming diagnostic and therapeutic developments in classical Hodgkin's lymphomaKristie A Blum
Hematology. American Society of Hematology. Education Program|December 10, 2021
Controversies in the management of early-stage Hodgkin lymphomaKristie A Blum
Cancer Journal (Sudbury, Mass.)|September 25, 2018
Treatment-Resistant Hodgkin Lymphoma: Defining the Role of Autologous TransplantationKristie A Blum
Hematology. American Society of Hematology. Education Program|December 6, 2015
B-cell receptor pathway modulators in NHLKristie A Blum
Current Treatment Options in Oncology|February 1, 2014
Ibrutinib in B-cell LymphomasKami Maddocks, Kristie A Blum
Cancer Treatment and Research|February 7, 2015
Treatment strategies in mantle cell lymphomaKami Maddocks, Kristie A Blum
Blood|November 19, 2015
How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplantLapo Alinari, Kristie A Blum
Expert Opinion on Biological Therapy|July 23, 2004
90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphomaKristie A Blum, Nancy L Bartlett
Seminars in Oncology|August 27, 2003
Antibodies for the treatment of diffuse large cell lymphomaKristie A Blum, Nancy L Bartlett
Pageof 14